Datong Concord Medical Cancer Center is affiliated to Concord Healthcare Group Co., Ltd, a domestic operation platform of Concord Holdings. The Center has 100 beds and is equipped with the advanced Swedish Elekta Precise-VMAT medical electron linear accelerator, Germany's Siemens MAGNETOM Essenza 1.5T TIM+DOT superconducting nuclear magnetic resonance system, Germany's Siemens Somatom Definition AS open Ct-Sim, Netherland’s Philips EPIQ5 color Doppler ultrasound diagnostic instrument, Japan’s OLYMPUS-CV290 electronic endoscope and other diagnostic equipment.

The Center is based on the needs of the region and faces the majority of patients. Relying on the high-quality medical resources of the Group in Beijing, Shanghai and Guangzhou and combining with international medical conditions, the Center conducts health examinations, oncology surgery, targeted chemotherapy, VMAT radiotherapy, pulmonary nodule specialists, and breast specialists, intangible cultural heritage - thunder fire moxibustion and other projects, and has achieved good social and economic benefits.

At the same time, the center has become the first batch of national key clinical specialties, Sino-Japanese Hospital integrated traditional Chinese and Western medicine oncology medical unit, Peking University Cancer Hospital telemedicine collaboration platform, and has carried out multidisciplinary medical collaboration and referral green channel with Peking University. The Center adheres to the construction concept of "Mastering medical skills with great virtues and Reaching perfection by advocating innovation", and wholeheartedly provides patients with accurate diagnosis and treatment services.